The Claim Game

Stemcentrx is a biotech unicorn that aims to create novel cancer therapeutics by targeting cancer stem cells.  Valuation: $5 Billion Patents: 23 Pending Patents: 2 Trademarks: 2 Competitors: Juno Therapeutics, Oncomed Pharmaceuticals, AbbVie Inc Most of Stemcentrx's patents involve anti-DLL3 antibodies. Some examples follow:  US9089617B2: Anti-DLL3 antibody drug conjugates US9090683: Methods of Detection, Diagnosis, and Monitoring Using Anti-DLL3 Antibodies US9155803: ANTI-DLL3

Blue Apron is a Unicorn that delivers ingredients and recipes for various meals to individuals seeking to learn more about cooking, and master gourmet techniques. One distinguishing factor between Blue Apron and its competitors is its delivery of wine, and wine pairing suggestions. Estimated Valuation: $2 Billion # of patents owned: 0 Competitors: HelloFresh, Plated, Instacart As an

Today I am going to discuss patent claims involved in the case Supreme Court case Teva Pharmaceuticals USA, Inc. v. Sandoz Inc.  Case Background: Teva sued Sandoz for patent infringement of Copaxone, a drug used to treat the neurological disorder Multiple Sclerosis. In defense, Sandoz claimed that Teva's patent claims were indefinite in that the term "molecular weight" had

Today I am going to discuss the key patent claims involved in Ariad Pharmaceuticals et al. v. Eli Lilly and Company.  Case Background: In this case, Ariad Pharma accused Eli Lilly of infringing on a patent regarding to Eli Lilly's osteoporosis medication and sepsis treatment. Though the lower court ruled in favor of Ariad, the appellate court reversed this

In 1996 Ian Wilmut and Keith Campbell from Roslin Institute pushed what was once thought of as science fiction into the realm of reality: mammalian cloning. From a scientific perspective, Dolly is undoubtedly a hallmark biotechnological innovation. However, Dolly the sheep was not awarded patent protection. ­­ The patent system is a legal mechanism that exists to incentivize

In the 1980s Harvard scientists introduced an oncogene, a gene that triggers tumor growth, to a mouse. This led to the production of the transgenic oncomouse: a genetically modified mouse especially susceptible to cancer. The oncomouse is a valuable model for cancer research. Given the scientific ingenuity put into innovating the oncomouse and its resulting value, Harvard applied